Current status of thrombolytic agents in acute cerebrovascular disease.
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000601:surgery; D002986:Clinical Trials as Topic; D005340:Fibrinogen; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000000981:diagnostic imaging; D011859:Radiography; D012212:Rheology; D055502:Secondary Prevention; D013300:Streptokinase / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D005340:Fibrinogen; D013300:Streptokinase